T1	Condition 27 46	lung adenocarcinoma
T2	Procedure 0 10	Pathologic
T3	Value 11 23	confirmation
R1	Has_value Arg1:T2 Arg2:T3	
T4	Qualifier 47 70	with measurable disease
R3	Has_qualifier Arg1:T1 Arg2:T4	
T5	Multiplier 83 95	at least one
T6	Condition 96 102	lesion
T7	Qualifier 108 160	can be accurately measured in at least one dimension
R4	Has_multiplier Arg1:T6 Arg2:T5	
R5	Has_qualifier Arg1:T6 Arg2:T7	
T8	Qualifier 232 241	untreated
T9	Qualifier 242 258	locally advanced
T10	Qualifier 262 272	metastatic
T11	Condition 273 278	NSCLC
*	OR T10 T9
T12	Scope 242 272	locally advanced or metastatic
R6	Has_scope Arg1:T11 Arg2:T12	
R7	Has_qualifier Arg1:T11 Arg2:T8	
T13	Condition 299 310	lung cancer
T14	Qualifier 311 315;329 353	with EGFR activating mutation
R8	Has_qualifier Arg1:T13 Arg2:T14	
T15	Condition 355 371	exon 19 deletion
T16	Condition 373 378	L858R
*	OR T15 T16
T17	Scope 355 378	exon 19 deletion, L858R
R9	Subsumes Arg1:T14 Arg2:T17	
T18	Scope 27 70	lung adenocarcinoma with measurable disease
R2	AND Arg1:T18 Arg2:T2	
R10	Subsumes Arg1:T18 Arg2:T6	
T19	Line 0 200	Pathologic confirmation of lung adenocarcinoma with measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded on CT)
T20	Line 202 278	Patients must have previously untreated locally advanced or metastatic NSCLC
T21	Line 280 380	Patients must have lung cancer with a documented EGFR activating mutation (exon 19 deletion, L858R).
